Hospital Mater Dei S.A. (BVMF:MATD3)
Brazil · Delayed Price · Currency is BRL 6.20
+0.27 (4.55%)
At close: Oct 7, 2026
Hospital Mater Dei Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,052 | 1,752 | 1,237 | 3,190 | 2,757 | 5,161 | |
Market Cap Growth | 40.25% | 41.61% | -61.22% | 15.72% | -46.59% | - |
Enterprise Value | 3,633 | 3,299 | 2,717 | 5,058 | 4,335 | 4,466 |
Last Close Price | 6.20 | 5.26 | 3.47 | 7.85 | 6.72 | 12.49 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.56 | 15.85 | - | 26.66 | 26.63 | 35.62 |
Forward PE | 10.04 | 11.84 | 9.50 | 15.73 | 15.67 | 23.77 |
PS Ratio | 0.88 | 0.81 | 0.56 | 1.46 | 1.56 | 5.04 |
PB Ratio | 1.36 | 1.19 | 0.84 | 1.82 | 1.62 | 3.07 |
P/TBV Ratio | 2.69 | 2.39 | 1.72 | - | - | 11.17 |
P/FCF Ratio | 11.25 | 9.91 | - | - | - | - |
P/OCF Ratio | 8.21 | 7.81 | 9.34 | 20.29 | 28.04 | 33.69 |
PEG Ratio | 0.27 | 1.71 | 0.93 | 0.69 | 0.58 | 1.01 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.57 | 1.52 | 1.22 | 2.31 | 2.46 | 4.36 |
EV/EBITDA Ratio | 7.21 | 7.68 | 6.53 | 10.82 | 10.83 | 16.11 |
EV/EBIT Ratio | 9.03 | 9.24 | 7.84 | 12.50 | 12.58 | 17.39 |
EV/FCF Ratio | 19.93 | 18.66 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.46 | 1.49 | 1.48 | 1.20 | 1.17 | 1.00 |
Debt / EBITDA Ratio | 4.35 | 4.82 | 4.90 | 4.21 | 4.62 | 5.73 |
Debt / FCF Ratio | 12.04 | 12.46 | - | - | - | - |
Net Debt / Equity Ratio | 1.04 | 1.07 | 1.02 | 1.01 | 0.94 | 0.25 |
Net Debt / EBITDA Ratio | 3.30 | 3.67 | 3.64 | 3.81 | 4.01 | 1.49 |
Net Debt / FCF Ratio | 8.59 | 8.92 | -21.82 | -69.65 | -6.92 | -2.26 |
Asset Turnover | 0.53 | 0.50 | 0.47 | 0.43 | 0.39 | 0.39 |
Inventory Turnover | 25.03 | 25.08 | 27.55 | 23.16 | 22.89 | 22.35 |
Quick Ratio | 2.65 | 2.82 | 2.95 | 2.34 | 2.26 | 4.82 |
Current Ratio | 2.87 | 3.04 | 3.16 | 2.59 | 2.62 | 5.05 |
Return on Equity (ROE) | 9.52% | 7.58% | -20.05% | 8.17% | 7.25% | 15.11% |
Return on Assets (ROA) | 5.76% | 5.16% | 4.55% | 5.00% | 4.77% | 6.09% |
Return on Invested Capital (ROIC) | 8.68% | 7.92% | 10.62% | 8.00% | 8.42% | 12.54% |
Return on Capital Employed (ROCE) | 10.50% | 9.30% | 8.90% | 8.60% | 7.70% | 6.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.91% | 6.31% | -27.36% | 3.75% | 3.75% | 2.81% |
FCF Yield | 8.88% | 10.09% | -5.61% | -0.80% | -8.41% | -3.54% |
Dividend Yield | 2.43% | 2.86% | 2.16% | 0.89% | 0.95% | 0.72% |
Payout Ratio | 35.26% | 68.12% | - | 20.54% | 57.01% | 18.83% |
Buyback Yield / Dilution | 5.47% | 10.34% | 7.18% | 1.30% | -23.74% | 1.65% |
Total Shareholder Return | 8.01% | 13.21% | 9.34% | 2.20% | -22.79% | 2.37% |